Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Lenvatinib by AiViva BioPharma for Diabetic Macular Edema: Likelihood of Approval
Lenvatinib is under clinical development by AiViva BioPharma and currently in Phase II for Diabetic Macular Edema. According to GlobalData,...
Data Insights
AIV-001 by AiViva BioPharma for Basal Cell Carcinoma (Basal Cell Epithelioma): Likelihood of Approval
AIV-001 is under clinical development by AiViva BioPharma and currently in Phase II for Basal Cell Carcinoma (Basal Cell Epithelioma)....